Beyond established covariates (Daily dose, ALB, eGFR, PLT, urea), we newly identified five clinical variables (HGB, AST, IBIL, TBIL, and DBIL) as mechanistic predictors of TEIC exposure in liver disease patients. Here, CYGB is linked to liver disorder.